FHS-NEXT - Framingham Novel EXam using Technology

FHS-NEXT - 使用技术的弗雷明汉小说考试

• 批准号: 10311514
• 负责人: Emelia J. Benjamin
• 金额: $ 61.58万
• 依托单位: BOSTON UNIVERSITY MEDICAL CAMPUS
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-12-15 至 2024-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10311514
• 关键词: Address; Adherence; Affect; Age; Apple; Behavior; Behavioral Sciences; Big Data; Blood Pressure; Blood Vessels; Cardiopulmonary; Cardiovascular Diseases; Cardiovascular system; Charge; Clinic; Clinical; Clinical Research; Cohort Studies; Communication; Communities; Custom; Data; Data Collection; Development; Devices; Disease; Disease Surveillance; Documentation; Epidemiology; Event; Evolution; Exercise; Exercise Test; Failure; Framingham Heart Study; Funding; Generations; Goals; Gold; Grant; Health; Health Technology; Health behavior; Heart Rate; Home; Home Blood Pressure Monitoring; Hypertension; Individual; Informatics; Interdisciplinary Study; Knowledge; Life Style; Measures; Medical; Methods; Modeling; Monitor; Nature; Oxygen; Participant; Persons; Phenotype; Physiologic pulse; Publishing; Recovery; Reporting; Research; Research Methodology; Resources; Rest; Risk Factors; Secure; Seminal; Surveys; System; Technology; Testing; Time; Training; United States National Institutes of Health; Work; World Health; arterial stiffness; arterial tonometry; base; blood pressure variability; cardiovascular disorder epidemiology; cardiovascular disorder risk; cardiovascular fitness; cardiovascular health; clinical epidemiology; clinical practice; cohort; data integration; database of Genotypes and Phenotypes; design; digital; digital health; disease phenotype; epidemiology study; exercise capacity; fitness; handheld mobile device; health data; improved; innovation; insight; mHealth; multi-ethnic; multidisciplinary; novel; prototype; sensor; sex; smart watch; smartphone Application; standard measure; tonometry; uptake; usability; user-friendly

Abstract Traditional epidemiology cohorts have contributed greatly to our understanding of CVD and its risk factors, but concerns have been raised about their resource intensive nature, as well as their failure to integrate data from outside the research center. Digital and mobile health (mHealth) technologies provide data on individuals’ behaviors, risk factors, and CVD events. The growing ubiquity of mHealth solutions provides an unprecedented opportunity to add novel “real world” cardiovascular phenotypes to cohort studies. MHealth may facilitate more frequent, convenient, and meaningful interactions with cohort participants. Despite the availability of myriad devices, few systems have been designed to facilitate long-term cardiovascular phenotyping and CVD surveillance. We propose to enhance the FHS-NExT (Framingham Heart Study-Novel Examination using Technology) system, which includes a custom smartphone application (app) and data from a smartwatch (heart rate/steps) and digital blood pressure (BP) cuff, for use by FHS Generation 3 (Gen3) and multi-ethnic Omni 2 participants. We will identify factors associated with long-term adherence, and relations between mHealth and digital phenotypes with validated measures of fitness and arterial stiffness. Specific aims: Aim 1. Enhance the FHS-NExT smartphone app to promote adherence and compare the new FHS-NExT app CVD risk factor surveys against conventional measures in the FHS Research Center. We will enhance the FHS-NExT app, add new messaging and interactive capabilities to facilitate long-term use of the FHS-NExT app (n=2250), smartwatch (n=1500), and BP device (n=1500) and correlate FHS CVD risk score as assessed using the app to the FHS CVD risk score from the research center exam. Aim 2. Identify factors associated with successful long-term use of the FHS-NExT system, including the app, smartwatch, and digital BP device. System adherence will be defined based on: 1) app completion of lifestyle and CVD risk factor surveys every 3 months (n=2250); 2) donning the smartwatch and recording ≥1000 steps daily (n=1500); and 3) taking BP measures ≥once weekly (n=1500). We will identify participant or system-related factors, that affect adherence to the FHS-NExT system (n=1500 participants) over 12 months. Aim 3. Examine relations of novel exercise capacity measures by cardiopulmonary exercise testing (CPET) with average resting HR and daily step counts from smartwatch recordings over 30 days. Aim 4. Examine relations of arterial stiffness by tonometry with mean weekly BP and mean BP variability over 6 months. We bring together a highly productive, multi-disciplinary team with expertise in app development, mHealth and digital research methods and analysis, “big data” integration, behavioral science, & CVD epidemiology. We propose to build new, scalable capabilities for digital and mHealth data collection, and test the relations between traditional in-clinic measures of cardiovascular fitness and arterial tonometry and novel mHealth phenotypes.

抽象的 传统的流行病学队列对我们对 CVD 及其危险因素的理解做出了巨大贡献，但是 人们对其资源密集型性质以及未能整合来自 研究中心外的数字和移动健康（mHealth）技术提供有关个人的数据。 移动医疗解决方案的日益普及提供了前所未有的机会。 将新的“现实世界”心血管表型添加到队列研究中的机会可能会促进更多。 尽管有无数的可用资源，但仍能与群体进行频繁、方便且有意义的互动。 设备，很少有系统被设计来促进长期心血管表型分析和 CVD 我们建议加强 FHS-NExT（弗雷明汉心脏研究 - 新颖检查）。 技术）系统，其中包括定制智能手机应用程序（app）和来自智能手表的数据 （心率/步数）和数字血压 (BP) 袖带，供 FHS 第 3 代 (Gen3) 和多种族人士使用 我们将确定与长期坚持相关的因素以及之间的关系。 移动健康和数字表型，具有经过验证的健康和动脉僵硬度测量方法。 目标 1. 增强 FHS-NExT 智能手机应用程序以促进依从性并比较新的 FHS-NExT 我们将在 FHS 研究中心针对常规措施进行 CVD 风险因素调查。 增强FHS-NExT应用程序，添加新的消息传递和交互功能，以方便长期使用 FHS-NExT 应用程序 (n=2250)、智能手表 (n=1500) 和 BP 设备 (n=1500) 并将 FHS CVD 风险评分关联为 使用该应用程序根据研究中心考试的 FHS CVD 风险评分进行评估。 目标 2. 确定与成功长期使用 FHS-NExT 系统相关的因素，包括 应用程序、智能手表和数字血压设备的依从性将基于以下因素进行定义：1) 应用程序完成情况。 每 3 个月进行一次生活方式和 CVD 危险因素调查 (n=2250)；2) 佩戴智能手表并进行记录 每天 ≥1000 步 (n=1500)；以及 3) 每周进行一次血压测量 (n=1500)。 系统相关因素，影响 12 个月内对 FHS-NExT 系统（n=1500 名参与者）的遵守情况。 目标 3. 通过心肺运动测试检查新运动能力测量的关系 (CPET)，包含 30 天内智能手表记录的平均静息心率和每日步数。 目标 4. 通过张力测量检查动脉僵硬度与平均每周血压和平均血压的关系 6个月内的变化。 我们汇集了一支高效、多学科的团队，他们在应用程序开发、移动医疗和 数字研究方法和分析、“大数据”整合、行为科学和CVD流行病学。 建议为数字和移动医疗数据收集建立新的、可扩展的能力，并测试之间的关系 心血管健康和动脉张力测量的传统临床测量以及新颖的移动健康表型。

项目成果

Medication cost-reducing behaviors in older adults with atrial fibrillation: The SAGE-AF study.

• DOI: 10.1016/j.japh.2022.08.030
• 发表时间: 2023-01
• 期刊: JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
• 影响因子: 2.1
• 作者: Bamgbade, Benita A.;McManus, David D.;Briesacher, Becky A.;Lessard, Darleen;Mehawej, Jordy;Gurwitz, Jerry H.;Tisminetzky, Mayra;Mujumdar, Sarika;Wang, Weija;Malihot, Tanya;Abu, Hawa O.;Waring, Molly;Sogade, Felix;Madden, Jeanne;-Louis, Isabelle C. Pierre;Helm, Robert;Goldberg, Robert;Kramer, Arthur F.;Saczynski, Jane S.
• 通讯作者: Saczynski, Jane S.

Differences in Perceived and Predicted Bleeding Risk in Older Adults With Atrial Fibrillation: The SAGE-AF Study.

• DOI: 10.1161/jaha.120.019979
• 发表时间: 2021-09-07
• 期刊: Journal of the American Heart Association
• 影响因子: 5.4
• 作者: Bamgbade BA;McManus DD;Helm R;Mehawej J;Gurwitz JH;Mailhot T;Abu HO;Goldberg R;Wang Z;Tisminetzky M;Pierre-Louis IC;Saczynski JS
• 通讯作者: Saczynski JS

Is Catheter Ablation Associated with Preservation of Cognitive Function? An Analysis From the SAGE-AF Observational Cohort Study.

导管消融与认知功能的保留有关吗？

• DOI: 10.1101/2023.11.20.23298768
• 发表时间: 2023
• 期刊: medRxiv : the preprint server for health sciences
• 作者: Srichawla,BahadarS;Hamel,AlexanderP;Cook,Philip;Aleyadeh,Rozaleen;Lessard,Darleen;Otabil,EdithM;Mehawej,Jordy;Saczynski,JaneS;McManus,DavidD;Moonis,Majaz
• 通讯作者: Moonis,Majaz

Clinically Meaningful Change in Quality of Life and Associated Factors Among Older Patients With Atrial Fibrillation.

• DOI: 10.1161/jaha.120.016651
• 发表时间: 2020-09-15
• 期刊: Journal of the American Heart Association
• 影响因子: 5.4
• 作者: Abu HO;Saczynski JS;Mehawej J;Tisminetzky M;Kiefe CI;Goldberg RJ;McManus DD
• 通讯作者: McManus DD

Prognostic value of geriatric conditions for death and bleeding in older patients with atrial fibrillation.

老年病对老年心房颤动患者死亡和出血的预后价值。

• DOI: 10.1016/j.ijcha.2021.100739
• 发表时间: 2021-04
• 期刊: International journal of cardiology. Heart & vasculature
• 作者: Wang W;Lessard D;Saczynski JS;Goldberg RJ;Mehawej J;Gracia E;McManus DD
• 通讯作者: McManus DD